about us

Drug Hunter™ is an essential resource for the community of R&D innovators turning molecules into medicines. Drug Hunter distills the science behind emerging drugs and technologies into an easy-to-read and simple-to-search reference. The company was founded in 2018 out of a scientist’s frustration with existing ways to learn about new drugs and the science of pharma. Now, thousands of R&D leaders from every major pharma and biotech company in the world choose to invest their time in Drug Hunter over crawling through the literature alone.

Our products and subscription services including drughunter.com, the Drug Hunter Newsletter, Drug Hunter Events, and Drug Hunter Premium subscription distill the science behind drug discovery, helping innovators keep up with best practices, find ideas, and identify partners with a fraction of the time and cost. Drug Hunter products and services are used by researchers at every major pharma and biotech in the world, leading universities like Harvard, and top VC and equity research firms.

What is a Drug Hunter? | Our Mission | Our Values | Why We Started

If you’re here reading about drug discovery for fun, you’re probably a drug hunter. If so, we’re here to help!

Our Mission

Our mission is to empower the innovators seeking tomorrow’s medicines. We’ve started to accomplish this by providing products and services that help drug hunters at every stage of drug discovery, from finding new ideas to discovering partners for their clinical candidates. Drughunter.com is the go-to resource for drug discovery innovators to learn and grow their careers in modern drug discovery. Our Drug Hunter newsletter inspires leaders in nearly every pharmaceutical R&D company worldwide with examples of molecules that matter. Experienced professionals can get the science behind emerging drugs served directly with a Premium subscription. Drug Hunter Events are the best place to connect with our community of drug discovery innovators. We’re constantly finding new ways to support drug hunters, and this is just the beginning.

Subscribers to Drug Hunter typically have >12 years of industry experience, nearly half have been drug hunting for two decades or longer, and a significant number serve as senior executives at major public pharma and biotech companies. Drug Hunter subscribers work in every major public pharma and biotech company in the world, act as venture capitalists and investors, and are generally interested in bringing useful medicines to society.

Our Values

We believe in:

Facts: we’re built on science and data, not opinion or manipulation

Community: drugs are discovered by a community effort, not individuals

Clarity: effective communication is key in a team sport like drug discovery

Curation: your time is valuable, so our information is visual, contextualized, easy to access and comprehend

Context: “why” matters – we don’t share information without tying it to why its important

Why We Started

We love the science and impact of drug discovery. We were tired of seeing only negative press about our amazing industry, so we decided to build something online that’s useful to people like us.

Drug Hunter exists to help drug hunters do what they do best, and celebrate the milestones and knowledge-generating setbacks along the way. Drug Hunter was founded by a drug discovery scientist, and will always be run with a science focus.

If there are more ways we can help you, or if you want to help us in our mission, please get in touch!

NEWSLETTER

Learn More

Testimonials

“I look forward to reading the summaries that come out every month. It helps me keep up to date on what’s going on in the industry.”

Hilary Beck

Vice President, Head of Chemistry, Eikon Therapeutics / VC-Backed Biotech
“Drug Hunter has been great. I regularly check with my team and they all say they like it and use it. The molecule highlights are great. My team has benefited from this site with keeping up to date of the latest and greatest. Drug Hunter definitely distinguishes itself from other science websites. Drug Hunter provides facts, data and information that we can learn from. I…

Anthony Romero

Director, Head of Chemistry, ORIC Pharma
“I like Drug Hunter! I realize that the team puts so much time and effort into this work and it is not easy work. It is a key opinion leader in the industry. I want Drug Hunter to go on forever. It’s really good!”

Mark Baik

Founder and CEO, Arum Therapeutics / Privately Held Biotech
“Your article prompted me to obtain access to your “Premium” collection and I was pleasantly surprised to discover multiple examples that were high quality, even though they were not peer reviewed publications. I then spent some more time on your site and was pleased to discover that it included resources useful to any medicinal chemist.”

Peter Bernstein

Principal, SAB Member, Editor
“Firstly, I would like to thank you for the great work that you are doing. I am an avid follower of the Drug Hunter website and find the resources provided to be invaluable. The PK cheat sheet, Topliss tree information, and concise updates on industry developments are particularly noteworthy.”

Nilesh Zaware

Principal Scientist, Halda Therapeutics
“The thing I like most about it is the concise, to-the-point presentation of the relevant information in an easily digestible format, that is readily accessible to all, from experienced drug hunters to scientists who are just starting their careers. The time-savings achieved by using Drug Hunter are another major selling point. Keep up the good work, folks!”

David Barrett

Executive Director, Science and Strategy Advisor, Astellas Pharma
“I find your website really useful, especially the case studies. The chemists and I use it and it helps us keep our finger on the pulse of such an evolving field.”

Steven Van der Plas

Director, Medicinal Chemistry, iTEOS Therapeutics
“When I need to find information, I know that I can find it on Drug Hunter. This is what was always missing in our field. I’ve been designing drugs for years and the most frustrating part is learning on your own. You may need to go through hundreds of articles to find the information you need. Drug Hunter cuts down on a lot of this!”

Berenger Biannic

Associate Director, Drug Discovery, Essa Pharma / Publicly Listed Biotech
“I like that the content is written in a straightforward style.”

Ryan Henry

Associate Director, Aleksia Therapeutics
“Drug Hunter helps keep me up to date with the scientific literature and saves me so much valuable time. Please continue the excellent work!”

Vincent Guerlavais

Senior Director of Medicinal Chemistry, Sarepta Therapeutics / Publicly Listed Biotech
“Drug Hunter has a great overview of what is happening in our field, saves time on scouring through news feeds, literature and irrelevant stuff that comes up. It is a tool specifically for people like me to weed out the noise. Big time saver.”

Cyril Bucher

Drug Discovery Scientist, Denali Therapeutics / Publicly Listed Biotech
“The cheat sheets that are published are great. Having a centralized resource of those is super helpful. When I recently onboarded a new team member, I taught her about Topliss trees using Drug Hunter. I am way more on top of the med. chem literature because of Drug Hunter!”

Benjamin Horning

Senior Scientist, Medicinal Chemistry, Vividion Therapeutics
“I think the content is VERY comprehensive and caters to a wide audience ranging from early stage drug discovery scientists to seasoned drug hunters, whether that be in smaller biotechs or large pharma companies. The standout feature for me is the “molecules of the month”, as it serves as a source of inspiration for coming up with new design ideas for one’s own projects. I…

Daljit Matharu

Sr. Scientist, Large Pharma
Personally, I find the premium subscription very useful. As you mentioned in your talk it is hard to find all the information on the latest approvals and trials in a distilled and ready to consume fashion. So, I really appreciate the work done by the DH group.

Karthik Iyer

Principal Scientist, Arrakis Therapeutics
“I really like how you give a meaty, but not overwhelming, amount of information on the background of the targets, the competitive landscape and even the chemistry. Highlights of the synthesis and SAR for a unique motif is arguably the most important content I could gather from your website. The cheat sheets are nice and handy.”

Kiel Lazarski

Sr. Scientist II, Biotech
“As both an academic and (most recently) an industrial medicinal chemist, the Drug Hunter resources have been very helpful so far. I’ve passed along several of the excellent primer/cheat sheets to my own students, and the lists of CROs and investors have been helpful for company building. Of course, the Molecules of the Month, and the deep science and strategy behind their structures shared in…

Chris Dockendorff

Academic, Industrial Chemist
“I don’t know of anything similar to this. It’s great that I can visit the site and get a pointer to recent important papers in the field. With the article annotations, I also get a perspective I may not get just by reading papers myself.”

Matthew Robinson

Computational Chemist, PostEra
“I know I can find new information, targets, and compounds on Drug Hunter each month, which has been really helpful. It’s a good website to see the latest news in drug discovery!”

TJ Bing

Senior Group Leader, Pharmaron